Ultragenyx Pharmaceutical(MX:RARE)
MX$256.000.00 (0.00%)
MX:RARE
Ultragenyx Pharmaceutical earnings date
MX$256.00
At close:0.00 (0.00%)
Ultragenyx Pharmaceutical (RARE) Q1 2023 Earnings Report
1 Followers
MX:RARE Q1 2023 EPS Results
- Actual EPS
- -MXN 43.14
- Consensus EPS
- -MXN 36.88
- Beat/Miss
- Missed by -MXN 6.26
- One Year Ago EPS
- -MXN 40.55
MX:RARE Q1 2023 Revenue Results
- Actual Revenue
- MXN 1.86B
- Expected Revenue
- MXN 1.94B
- Beat/Miss
- Missed by -MXN 78.12M
- YoY Revenue Growth
- +25.72%
Earnings Announcement Details
- Quarter
- Q1 2023
- Date
- 05/04/2023
- Time
- After Close
- Conference Call
- Thursday, May 4, 2023
MX:RARE Upcoming Earnings
Ultragenyx Pharmaceutical's next earnings date is estimated for February 18, 2027, based on past reporting schedules.
Q1 2023 Earnings Call Audio
MX:RARE Q1 2023 Earnings Call
0:00 / 0:00
Q1 2023 Earnings Slide Deck
Q1 2023 Earnings Call Summary
No earnings call summary is available for this earnings event.
MX:RARE Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 18, 2027 | 2026 (Q4) | 43.83- | -23.88 | ― | ― |
| Nov 03, 2026 | 2026 (Q3) | -20.37-21.48 | -33.51 | 35.91% (+12.03) | |
| Aug 04, 2026 | 2026 (Q2) | -23.00-16.66 | -21.66 | 23.08% (+5.00) | |
| May 05, 2026 | 2026 (Q1) | -27.55-34.07 | -29.07 | -17.20% (-5.00) | |
| Feb 12, 2026 | 2025 (Q4) | -20.24-23.88 | -25.74 | 7.19% (+1.85) | |
| Nov 04, 2025 | 2025 (Q3) | -22.85-33.51 | -25.92 | -29.29% (-7.59) | |
| Aug 05, 2025 | 2025 (Q2) | -24.01-21.66 | -28.14 | 23.03% (+6.48) | |
| May 06, 2025 | 2025 (Q1) | -29.59-29.07 | -37.59 | 22.66% (+8.52) | |
| Feb 13, 2025 | 2024 (Q4) | -24.22-25.74 | -28.14 | 8.55% (+2.41) | |
| Nov 05, 2024 | 2024 (Q3) | -27.48-25.92 | -41.29 | 37.22% (+15.37) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed


